Rallybio CorpRLYBEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Rallybio Corp is a clinical-stage biotechnology company dedicated to developing transformative therapies for patients with severe, rare diseases with high unmet medical needs. Its core development pipeline targets hematologic disorders, fetal and neonatal hemolytic disease, and complement-mediated conditions, serving patient populations primarily in North America and Europe.